Optimization of PEGylated nanoemulsions for improved pharmacokinetics of BCS class II compounds

References

• Amin K, Dannenfelser RM. (2006). In vitro hemolysis: guidance for the pharmaceutical scientists. J Pharm Sci 95:1173–6
   PubMed Web of Science ®Google Scholar
• Backmann N, Kappeler N, Braun T, et al. (2010). Sensing surface PEGylation with microcantilevers. Beilstein J Nanotechnol 1:3–13
   Google Scholar
• Chaudhari KR, Ukawala M, Manjappa AS, et al. (2012). Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm Res 29:53–68
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev 60:757–67
   PubMed Web of Science ®Google Scholar
• Devalapally H, Silchenko S, Zhou F, et al. (2013). Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs. J Pharm Sci 102:3808–15
   PubMed Web of Science ®Google Scholar
• Dudrick SJ. (2009). History of parenteral nutrition. J Am Coll Nutr 28:243–51
   PubMed Web of Science ®Google Scholar
• Erlich L, Yu D, Pallister DA, et al. (1999). Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules. Int J Pharm 179:49–53
   PubMed Web of Science ®Google Scholar
• Fischer D, Osburg B, Petersen H, et al. (2004). Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynycleotides in mice. Drug Metab Dispos 32:983–92
   PubMed Web of Science ®Google Scholar
• Ganta S, Devalapally H, Baguley B, et al. (2008). Microfluidic preparation of chlorambucil nanoemulsion formulation and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. J Biomed Nanotechnol 4:165–73
   Web of Science ®Google Scholar
• Hong RL, Huang CJ, Tseng YL, et al. (1999). Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?. Clin Cancer Res 5:3645–52
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y. (2007). Formulation consideration of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy. Curr Drug Deliv 4:131–40
   PubMedGoogle Scholar
• Jiang SP, He SN, Li YL, et al. (2013). Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. Int J Nanomed 8:3141–50
   PubMed Web of Science ®Google Scholar
• Klibanov AL, Maruyama K, Torchilin VP, Huang L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–7
   PubMed Web of Science ®Google Scholar
• Krzyzaniak JF, Alvarez Núñez FA, Raymond DM, Yalkowsky SH. (1997). Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J Pharm Sci 86:1215–17
   PubMed Web of Science ®Google Scholar
• Liu F, Liu D. (1995). Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs. Pharm Res 12:1060–4
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
   PubMed Web of Science ®Google Scholar
• Owen DE III, Peppas NA. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
   PubMedGoogle Scholar
• Roser M, Fischer D, Kissel T. (1998). Surface-modified biodegradable albumin nano- and microspheres. II. Effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255–63
   PubMed Web of Science ®Google Scholar
• Shah P, Bhalodia D, Shelat P. (2010). Nanoemulsion: a pharmaceutical review. Syst Rev Pharm 1:24–32
   Google Scholar
• Shan X, Liu C, Yuan Y, et al. (2009). In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf B Biointerfaces 72:303–11
   PubMed Web of Science ®Google Scholar
• Sheng Y, Yuan Y, Liu C, et al. (2009). In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. J Mater Sci Mater Med 20:1881–91
   PubMed Web of Science ®Google Scholar
• Shibuya-Fujiwara N, Hirayama F, Ogata Y, et al. (2001). Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. Life Sci 70:291–300
   PubMed Web of Science ®Google Scholar
• Singh M, Ravin LJ. (1986). Parenteral emulsions as drug carrier system. J Parenter Sci Technol 40:34–41
   PubMedGoogle Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201–30
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
   PubMed Web of Science ®Google Scholar
• Van Vlerken LE, Vyas TK, Amiji M. (2007). Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405–14
   PubMed Web of Science ®Google Scholar
• Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharm Res 62:90–9
   Web of Science ®Google Scholar
• Woodburn K, Chang CK, Lee S, et al. (1994). Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem Photobiol 60:154–9
   PubMed Web of Science ®Google Scholar
• Yamaoka T, Tabata Y, Ikada Y. (1994). Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 83:601–6
   PubMed Web of Science ®Google Scholar
• Yang A, Liu W, Li Z, et al. (2010). Influence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation. J Nanosci Nanotechnol 10:622–8
   PubMed Web of Science ®Google Scholar